iCAD, Inc. (ICAD)
NASDAQ: ICAD · Real-Time Price · USD
1.890
+0.030 (1.61%)
Nov 7, 2024, 4:00 PM EST - Market closed

iCAD, Inc. Revenue

iCAD, Inc. had revenue of $5.03M in the quarter ending June 30, 2024, with 20.57% growth. This brings the company's revenue in the last twelve months to $18.80M, up 7.40% year-over-year. In the year 2023, iCAD, Inc. had annual revenue of $17.32M, down -12.54%.

Revenue (ttm)
$18.80M
Revenue Growth
+7.40%
P/S Ratio
2.59
Revenue / Employee
$272,391
Employees
69
Market Cap
49.81M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202317.32M-2.48M-12.54%
Dec 31, 202219.80M-13.84M-41.13%
Dec 31, 202133.64M3.94M13.27%
Dec 31, 202029.70M-1.64M-5.24%
Dec 31, 201931.34M5.72M22.32%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cytosorbents 37.16M
Rapid Micro Biosystems 26.17M
Aadi Bioscience 25.07M
SCYNEXIS 8.57M
LAVA Therapeutics 7.40M
OncoCyte 1.02M
Revenue Rankings